Your browser doesn't support javascript.
loading
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients.
Marcolino, M S; Boersma, E; Clementino, N C D; Macedo, A V; Marx-Neto, A D; Silva, M H C R; van Gelder, T; Akkerhuis, K M; Ribeiro, A L.
Affiliation
  • Marcolino MS; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Electronic address: milenamarc@gmail.com.
  • Boersma E; Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.
  • Clementino NCD; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Hematology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Macedo AV; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Hematology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Marx-Neto AD; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Silva MHCR; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • van Gelder T; Departments of Internal Medicine; Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.
  • Akkerhuis KM; Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.
  • Ribeiro AL; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Cardiology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Ann Oncol ; 22(9): 2073-2079, 2011 Sep.
Article in En | MEDLINE | ID: mdl-21310760

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Acute Kidney Injury / Kidney Failure, Chronic / Antineoplastic Agents Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Acute Kidney Injury / Kidney Failure, Chronic / Antineoplastic Agents Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article